| Issue |
Med Sci (Paris)
Volume 22, Number 4, Avril 2006
|
|
|---|---|---|
| Page(s) | 348 - 350 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/2006224348 | |
| Published online | 15 April 2006 | |
Du cancer au traitement du diabète
Le suppresseur de tumeur LKB1 comme nouvelle cible pharmacologique
Cancer towards diabetes treatment: the suppressor of tumor LKB1 as a new pharmacological target
1
Institut Cochin, Département Endocrinologie, Métabolisme et Cancer, 24, rue du Faubourg Saint-Jacques, 75014 Paris, France
2
Unité Hormones et Métabolisme, Institut Christian de Duve de Pathologie Cellulaire, 75, avenue Hippocrate, B-1200 Bruxelles, Belgique
*
foretz@cochin.inserm.fr
*
viollet@cochin.inserm.fr
*
Bruno.Guigas@horm.ucl.ac.be
Cet article ne possède pas de résumé.
© 2006 médecine/sciences - Inserm / SRMS
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.
